Wednesday, April 8, 2026 at 7:00 AM
Online Streaming Available
April 8th, 2026 1.00 AMA PRA Category 1 Credit Hours
Description
Our talk will review current pharmacologic modalities for acute pain — including opioids, NSAIDs, and adjuvants — covering mechanisms, limitations, and recent literature, before pivoting to the emerging field of selective sodium channel blockade. The centerpiece is a focused review of Nav1.8 as a peripheral nociceptor-specific target and suzetrigine (JOURNAVX™), the first new non-opioid analgesic class in over 25 years, including Phase 3 trial data, safety profile, and the future of Nav-targeted analgesia in multimodal pain management.
Dates and Times
Start: 4/8/2026 7:00 AM
End: 4/8/2026 8:00 AM
Objectives
1. Review current systemic and regional pharmacologic modalities, mechanisms, and limitations of treating perioperative pain.
2. Review selective voltage-gated sodium channel blockade as a therapeutic strategy, with a focus on Nav1.8.
3. Evaluate the current clinical evidence for suzetrigine (JOURNAVX™) and ongoing investigations in multimodal acute pain management.
Speakers
Location
Stony Brook Medicine
HSC Level 3, lecture hall 5
HSC, Level 3. :Lecture Hall 5
Stony Brook, NY 11720
Accreditation
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Christine Fogarty
Department: Anesthesiology
Phone: 6314441614
Email: christine.fogarty@stonybrookmedicine.edu